JP2024523885A5 - - Google Patents
Info
- Publication number
- JP2024523885A5 JP2024523885A5 JP2023577514A JP2023577514A JP2024523885A5 JP 2024523885 A5 JP2024523885 A5 JP 2024523885A5 JP 2023577514 A JP2023577514 A JP 2023577514A JP 2023577514 A JP2023577514 A JP 2023577514A JP 2024523885 A5 JP2024523885 A5 JP 2024523885A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- antigen
- binding fragment
- seq
- her3
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2021099998 | 2021-06-15 | ||
| CNPCT/CN2021/099998 | 2021-06-15 | ||
| PCT/CN2022/098929 WO2022262772A1 (en) | 2021-06-15 | 2022-06-15 | Anti-her3 antibody, antibody drug conjugate containing the same, and use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024523885A JP2024523885A (ja) | 2024-07-02 |
| JP2024523885A5 true JP2024523885A5 (cg-RX-API-DMAC7.html) | 2025-06-20 |
Family
ID=84526843
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023577514A Pending JP2024523885A (ja) | 2021-06-15 | 2022-06-15 | 抗her3抗体、それを含有する抗体薬物複合体及びそれらの用途 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240293565A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4355787A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024523885A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240021294A (cg-RX-API-DMAC7.html) |
| CN (1) | CN117500832A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022293634A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3222478A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL309337A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023015072A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022262772A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4470570A1 (en) * | 2022-01-28 | 2024-12-04 | Duality Biologics (Suzhou) Co., Ltd. | Her3 antibody-drug conjugate and use thereof |
| WO2026145527A1 (zh) * | 2024-12-30 | 2026-07-09 | 映恩生物制药(苏州)有限公司 | 抗her3抗体药物偶联物的用途和使用方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1283053A1 (en) * | 2001-08-09 | 2003-02-12 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Inhibitors of HER3 activity |
| AR056857A1 (es) * | 2005-12-30 | 2007-10-24 | U3 Pharma Ag | Anticuerpos dirigidos hacia her-3 (receptor del factor de crecimiento epidérmico humano-3) y sus usos |
| NZ579644A (en) * | 2007-02-16 | 2012-05-25 | Merrimack Pharmaceuticals Inc | Antibodies against erbb3 and uses thereof |
| AU2010284018C1 (en) * | 2009-08-21 | 2015-10-15 | Merrimack Pharmaceuticals, Inc. | Antibodies against the ectodomain of ErbB3 and uses thereof |
| ME02637B (me) * | 2010-08-20 | 2017-06-20 | Novartis Ag | Antitela za receptor 3 faktora rasta epiderma (her3) |
| CA2813796C (en) * | 2010-10-18 | 2019-01-15 | Mediapharma S.R.L. | Erbb3 binding antibody |
| WO2013071058A1 (en) * | 2011-11-09 | 2013-05-16 | The Uab Research Foundation | Her3 antibodies and uses thereof |
| CN105367657B (zh) * | 2014-08-14 | 2019-09-13 | 上海生物制品研究所有限责任公司 | 抗her3抗体、其制法及其应用 |
| EP3091033A1 (en) * | 2015-05-06 | 2016-11-09 | Gamamabs Pharma | Anti-human-her3 antibodies and uses thereof |
| EP3176183A1 (en) * | 2015-12-02 | 2017-06-07 | Yeda Research and Development Co. Ltd | Compositions and methods for treating cancer not resistant to a tyrosine kinase inhibitor (tki) |
| US12667557B2 (en) * | 2017-02-28 | 2026-06-30 | Daiichi Sankyo Company, Limited | Method for treating EGFR-TKI-resistant non-small cell lung cancer by administration of anti-HER3 antibody-drug conjugate |
-
2022
- 2022-06-15 EP EP22824247.5A patent/EP4355787A4/en active Pending
- 2022-06-15 CA CA3222478A patent/CA3222478A1/en active Pending
- 2022-06-15 JP JP2023577514A patent/JP2024523885A/ja active Pending
- 2022-06-15 IL IL309337A patent/IL309337A/en unknown
- 2022-06-15 MX MX2023015072A patent/MX2023015072A/es unknown
- 2022-06-15 WO PCT/CN2022/098929 patent/WO2022262772A1/en not_active Ceased
- 2022-06-15 CN CN202280043063.8A patent/CN117500832A/zh active Pending
- 2022-06-15 AU AU2022293634A patent/AU2022293634A1/en active Pending
- 2022-06-15 KR KR1020247001430A patent/KR20240021294A/ko active Pending
- 2022-06-15 US US18/570,403 patent/US20240293565A1/en active Pending